Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a phase II, randomized, parallel-group, blinded-assessor, multicentre study to assess the non-inferiority of RD03/2016 eye drops vs. levofloxacin eye drops alone (1:1) in microbiological eradication in patients with a clinical diagnosis of bacterial conjunctivitis with moderate/severe signs.
Epistemonikos ID: 4537f6ea39ed23b124ea14e254b137fcc1a2947d
First added on: Oct 01, 2024